Rapamycin Might Slow Progress of Progeria

by Kathy Jones on  July 2, 2011 at 8:23 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

In what could prove to be a major breakthrough in treating patients suffering from Hutchinson-Gilford Progeria Syndrome, researchers have managed to slow down the progress of the disease using a drug known as rapamycin.
 Rapamycin Might Slow Progress of Progeria
Rapamycin Might Slow Progress of Progeria

Progeria disease is an extremely rare genetic disorder among children with just 78 children across the world currently suffering from the disease. The disease affects just one child in 8 million and has symptoms which resemble old age.

While there is no cure for the disease, a new study published in the Science Translational Medicine has revealed that researchers were able to slow down, and in some cases completely stop, its progress by using a drug known as rapamycin.

Lead researcher Dr Dimitri Krainc hoped that their study will pave way for a cure to the disease in the near future. "Part of the problem with aging starts when debris is accumulating in the cells and it's not getting removed, and this particular drug is able to enhance the removal process. It would be too optimistic to say this could completely cure Progeria patients, but we're hoping that this drug could make these kids live longer with fewer complications", Dr Krainc said.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Progeria 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive